lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
274 rows where filing_period = "third_quarter", filing_year = 2011 and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1144318 | MARSHALL BRACHMAN 976e97e4-f83b-4a20-903f-b2aed96a399b | Q3 | MARSHALL BRACHMAN | 6848 | BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM | 2011 | third_quarter | MED | support funding for medical research programs | HOUSE OF REPRESENTATIVES,SENATE | 33000 | 0 | 0 | 2011-10-02T22:00:56.330000-04:00 | |
| 1144331 | MARSHALL BRACHMAN dd36764f-1fd6-45f0-9974-b35b2072a82d | Q3 | MARSHALL BRACHMAN | 6848 | CARDIOVASCULAR OUTPATIENT CENTER ALLIANCE | 2011 | third_quarter | MED | reverse cardiac catheterization practice expense cuts | HOUSE OF REPRESENTATIVES,SENATE | 12000 | 0 | 0 | 2011-10-02T22:10:59.360000-04:00 | |
| 1144484 | TAKEDA PHARMACEUTICALS AMERICA, INC. 6b94c7f8-f4cb-4523-9af6-5c84d4f80955 | Q3 | TAKEDA PHARMACEUTICALS AMERICA, INC. | 57954 | TAKEDA PHARMACEUTICALS AMERICA INC | 2011 | third_quarter | MED | Regenerative Medicines Promotion Act; Gastrointestinal and Motility Disorders Research Enhancement Act (H.R. 2239); depression screening, end stage renal disease; | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE,Treasury, Dept of | 400000 | 0 | 0 | 2011-10-03T13:54:18.780000-04:00 | |
| 1144716 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 832e7946-b07c-4123-949a-2892f9fde929 | Q3 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | 400361684 | VIJUK EQUIPMENT, INC. | 2011 | third_quarter | MED | all issues relating to pharmaceutical labeling | 25000 | 0 | 0 | 2011-10-04T13:05:54.343000-04:00 | ||
| 1144722 | THE HARRIS FIRM 6b137de3-e6d0-4171-91f6-49f72eb0d2c2 | Q3 | THE HARRIS FIRM | 68376 | DIRECT MESSAGE LAB | 2011 | third_quarter | MED | Regarding funding for FY 11 pertaining to software communication system for chronic disease management | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-10-04T13:26:58.840000-04:00 | ||
| 1144766 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 4c48f14c-b905-43bf-aca0-8f03e3035426 | Q3 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2011 | third_quarter | MED | AACC joined with Members of the Clinical Laboratory Coalition in writing to Members of the House and Senate in opposing the adoption of a clinical laboratory co-payment as part of any debt reduction package. AACC joined with Members of the Clinical Laboratory Coalition in writing to members of the Joint Select Committee on Deficit Reduction in opposition to a clinical laboratory co-payment as part of any debt reduction package. AACC wrote separately to House and Senate Members of the Joint Select Committee on Deficit Reduction to oppose the establishment of a clinical laboratory co-payment as part of any debt reduction package. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-10-04T15:02:34.957000-04:00 | ||
| 1144849 | AMERICAN COLLEGE OF CLINICAL PHARMACY 34947c73-2a84-4032-9ca2-13ecde8cf4b2 | Q3 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2011 | third_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 59600 | 0 | 0 | 2011-10-05T09:52:10.183000-04:00 | |
| 1145271 | GRIZZLE COMPANY 2221c236-6dc6-4019-a109-21deac805794 | Q3 | GRIZZLE COMPANY | 16987 | UNIVERSITY OF LOUISVILLE | 2011 | third_quarter | MED | Request support for NIH grant application | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-10-06T14:41:45.107000-04:00 | |
| 1145310 | ASSN OF MEDICAL DEVICE REPROCESSORS 2dae1811-1072-469a-8f14-42947d0344d3 | Q3 | ASSN OF MEDICAL DEVICE REPROCESSORS | 291732 | ASSN OF MEDICAL DEVICE REPROCESSORS | 2011 | third_quarter | MED | Educated Congressional staff, members of Congress, and FDA officials on FDA-regulated, third-party reprocessing industry. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-06T15:30:16.683000-04:00 | |
| 1145525 | CEPHEID aee4906c-1b89-4370-a926-ba1704c67c80 | Q3 | CEPHEID | 400270233 | CEPHEID | 2011 | third_quarter | MED | See page five Lobbying Issues: molecular diagnostic tests, infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), hospital and other provider quality improvement programs CMS-related issues (reimbursement and coverage policies), FDA oversight, global health funding comparative effectiveness, personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues HR 436/ S 17, Protect Medical Innovation Act of 2011 HR 488, Save Our Medical Devices Act of 2011 HR 755, Investing in Our Future Act of 2011 HR 965/ S 1211, Preservation of Antibiotics for Medical Treatment Act of 2011 HR 2182 Generating Antibiotic Incentives Now (GAIN) S 660, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011 | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE | 40000 | 0 | 0 | 2011-10-07T14:02:11.433000-04:00 | |
| 1145554 | DALRYMPLE & ASSOCIATES, LLC 5dfd0530-8a0b-4713-9d2e-b86105d8a8a8 | Q3 | DALRYMPLE & ASSOCIATES, LLC | 5073 | DISCOVERY LABORATORIES | 2011 | third_quarter | MED | Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight. | Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 20000 | 0 | 0 | 2011-10-07T14:40:34.010000-04:00 | |
| 1145561 | DALRYMPLE & ASSOCIATES, LLC c72e8950-7683-4433-82f7-e49d60cf335e | Q3 | DALRYMPLE & ASSOCIATES, LLC | 5073 | BRIGHTON BIOTECH, INC. | 2011 | third_quarter | MED | Biodefense small molecule medical countermeasure against CBRN threats and orphan drug research and development funding, legislation, appropriations and oversight. | Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 16000 | 0 | 0 | 2011-10-07T14:54:35.007000-04:00 | |
| 1145569 | DALRYMPLE & ASSOCIATES, LLC 251b9293-0b6c-44e1-a563-4fd9c590ee7f | Q3 | DALRYMPLE & ASSOCIATES, LLC | 5073 | EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) | 2011 | third_quarter | MED | Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight. | Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 46000 | 0 | 0 | 2011-10-07T15:01:38.040000-04:00 | |
| 1145584 | DALRYMPLE & ASSOCIATES, LLC 53f3c3bd-24c3-41fc-9e7a-4139c11e1744 | Q3 | DALRYMPLE & ASSOCIATES, LLC | 5073 | SANOFI PASTEUR | 2011 | third_quarter | MED | Vaccine research and development legislation, funding, appropriations and oversight. | Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office | 46000 | 0 | 0 | 2011-10-07T15:13:50.350000-04:00 | |
| 1145714 | BEN BARNES GROUP LP 033a2194-e133-44e8-88ec-e370a868f0bc | Q3 | BEN BARNES GROUP LP | 5415 | FAIR LABORATORY PRACTICES ASSOCIATION | 2011 | third_quarter | MED | Bring attention to prevention of unfair billing practices by laboratories for Medicare services | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-08T14:19:11.060000-04:00 | |
| 1145722 | BEN BARNES GROUP LP 619c48d5-e6df-4ef3-b0e6-d818720a4cf7 | Q3 | BEN BARNES GROUP LP | 5415 | HUNTSMAN CANCER INSTITUTE | 2011 | third_quarter | MED | Medical Research | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-10-08T15:08:14.437000-04:00 | |
| 1145794 | FEDERAL SOLUTIONS, LLC 5da5ad5d-8592-4a5f-bf61-c22c2e0b2695 | Q3 | FEDERAL SOLUTIONS, LLC | 311371 | JACKSONVILLE STATE UNIVERSITY | 2011 | third_quarter | MED | Labor/HHS/Education Appropriations Bill, 2011: Provisions relating to disease research, education, and development | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-10T10:21:30.523000-04:00 | |
| 1145810 | FEDERAL SOLUTIONS, LLC 7710b85b-4a2e-4fd5-a684-1b2cf0d9968d | Q3 | FEDERAL SOLUTIONS, LLC | 311371 | MISSISSIPPI STATE UNIVERSITY | 2011 | third_quarter | MED | Labor/HHS/Education Appropriations Bill, 2011: Provisions relating to disease research | Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Aeronautics & Space Administration (NASA),Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 50000 | 0 | 0 | 2011-10-10T10:30:34.057000-04:00 | |
| 1146244 | WAKE FOREST UNIVERSITY HEALTH SCIENCES 5b2d1981-5519-43cd-865d-7ef2e3043ff8 | Q3 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 6781 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2011 | third_quarter | MED | NIH Budget including Title VII & VIII programs VA-Outpatient Clinic in N.C.(RFP-land acquisition) America Invents Act HR1249 | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT),Veterans Affairs, Dept of (VA) | 160000 | 0 | 0 | 2011-10-11T10:51:25.287000-04:00 | |
| 1146318 | HOLLAND & KNIGHT LLP bcea67cd-d33e-429b-bf27-1a188807fec8 | Q3 | HOLLAND & KNIGHT LLP | 18466 | SHIRE PHARMACEUTICALS, INC | 2011 | third_quarter | MED | Advocate creation and funding of programs to support R&D for rare disease products, biosimilars and other products. Participate in FDA stakeholder meetings re Prescription Drug User Fee program. Met with FDA officials regarding programs to support development of products for rare diseases. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-10-11T11:32:09.710000-04:00 | |
| 1146321 | HOLLAND & KNIGHT LLP df45bb38-c683-42c7-acea-e5c0bcbd514e | Q3 | HOLLAND & KNIGHT LLP | 18466 | ALLIANCE FOR REGENERATIVE MEDICINE | 2011 | third_quarter | MED | Advocate for funding for regenerative medicine companies and researchers in universities; Advocate for NIH funding for regenerative medicine research. Advocate for funding for the FDA. Lobbied in support of HR 1862, The Regenerative Medicine Promotion Act of 2011. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),Natl Institutes of Health (NIH),SENATE | 80000 | 0 | 0 | 2011-10-11T11:32:10.710000-04:00 | |
| 1146643 | NATIONAL VENTURE CAPITAL ASSOCIATION 32208465-8c64-4443-8a60-8ee06580b950 | Q3 | NATIONAL VENTURE CAPITAL ASSOCIATION | 21687 | NATIONAL VENTURE CAPITAL ASSOCIATION | 2011 | third_quarter | MED | Personalized medicine: working with Congress to establish a regulatory approval and reimbursement path for advanced diagnostic products. NVCA submitted comments to FDA and CMS on their FDA/CMA parallel review draft proposal | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),Treasury, Dept of,White House Office | 506930 | 0 | 0 | 2011-10-11T15:36:10.037000-04:00 | |
| 1147027 | THE PETRIZZO GROUP, INC. fa287894-a420-44b6-865a-af8e892638d2 | Q3 | THE PETRIZZO GROUP, INC. | 305932 | FATE THERAPEUTICS, INC. | 2011 | third_quarter | MED | Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine for muscle regeneration by using the fundamental biological mechanisms that guide cell fate to develop innovative therapeutics. Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health. | Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-12T11:31:28.647000-04:00 | |
| 1147217 | THE PETRIZZO GROUP, INC. 3a26c701-7fdb-46c7-9013-4c48baf81f74 | Q3 | THE PETRIZZO GROUP, INC. | 305932 | SEATTLE CANCER CARE ALLIANCE | 2011 | third_quarter | MED | Advocated for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers. Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-12T13:25:19.457000-04:00 | |
| 1147235 | THE PETRIZZO GROUP, INC. 203cd8bb-e3ac-417c-80f1-be21e6b479f8 | Q3 | THE PETRIZZO GROUP, INC. | 305932 | SAGE THERAPEUTICS, INC. | 2011 | third_quarter | MED | Advocated for federal funding to support development of neuroactive steroids to yield therapeutics with a core focus on Traumatic Brain Injury (TBI), Post-Traumatic Stress Disorder (PTSD), and Pain. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-12T13:34:30.983000-04:00 | |
| 1147245 | THE PETRIZZO GROUP, INC. bc7e9ef2-b566-44a4-8696-fbcf758096b1 | Q3 | THE PETRIZZO GROUP, INC. | 305932 | SEATTLE BIOMEDICAL RESEARCH INSTITUTE | 2011 | third_quarter | MED | Advocated for funding to support next-generation drug development for Leishmaniasis. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-10-12T13:45:36.140000-04:00 | ||
| 1147280 | THE PETRIZZO GROUP, INC. 307c8298-4f44-4c2a-b289-f4fa15e1e83b | Q3 | THE PETRIZZO GROUP, INC. | 305932 | FRED HUTCHINSON CANCER RESEARCH CENTER | 2011 | third_quarter | MED | Advocated for level funding for the National Institutes of Health and National Cancer Institute for FY 2011federal funding. Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-12T14:04:58.547000-04:00 | |
| 1147327 | PALMETTO GROUP d1674a51-1932-49f4-888a-6fe424e0603d | Q3 | PALMETTO GROUP | 18570 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2011 | third_quarter | MED | Federal Funding of AIDS vaccine S.1601 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2012 | SENATE | 0 | 0 | 2011-10-12T14:37:28.943000-04:00 | ||
| 1147376 | AMERICAN ASSOCIATION OF COLLEGES OF NURSING e19cb891-9059-416e-bb6d-e422e9e18546 | Q3 | AMERICAN ASSOCIATION OF COLLEGES OF NURSING | 66911 | AMERICAN ASSOCIATION OF COLLEGES OF NURSING | 2011 | third_quarter | MED | Lobbied Members of Congress for additional nursing research funding in the FY 2012 LHHS Appropriations through the National Institutes of Health, National Institute of Nursing Research, and the Agency for Healthcare Research and Quality. | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Indian Health Service,Natl Institutes of Health (NIH),SENATE | 25000 | 0 | 0 | 2011-10-12T15:29:49.017000-04:00 | |
| 1147472 | MEHLMAN CONSULTING, INC. 3f3e16db-cac7-41d0-859c-285ce91eef01 | Q3 | MEHLMAN CONSULTING, INC. | 284950 | NATIONAL VENTURE CAPITAL ASSOCIATION | 2011 | third_quarter | MED | FDA reform: Changes to PDUFA (Prescription Drug User Fee Act) and MDUFA (Medical Device User Fee Act) programs. | HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of | 60000 | 0 | 0 | 2011-10-12T16:48:45.153000-04:00 | |
| 1147665 | FAEGRE BAKER DANIELS CONSULTING 58fc1020-4a8d-4530-80cc-f96708bd64d6 | Q3 | FAEGRE BAKER DANIELS CONSULTING | 34158 | ARTHRITIS FOUNDATION | 2011 | third_quarter | MED | NIH RESEARCH, CDC PUBLIC HEALTH, MEDICARE, CHILDREN'S HEALTH | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-10-13T10:37:44.883000-04:00 | |
| 1148198 | FRANCIS EDWARD & CRONIN, INC. c4406b28-186e-4e36-9be1-8fd275aa764a | Q3 | FRANCIS EDWARD & CRONIN, INC. | 311314 | CURE ALZHEIMER'S FUND | 2011 | third_quarter | MED | Legislation and issues related to Alzheimer's Disease Research | Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl AIDS Policy,SENATE,White House Office | 10000 | 0 | 0 | 2011-10-13T15:22:10.263000-04:00 | |
| 1148353 | EDWARDS WILDMAN PALMER LLP 8b30ccf2-9c78-4d72-8a64-f3e2ef40c9f6 | Q3 | EDWARDS WILDMAN PALMER LLP | 400309447 | ELUSYS THERAPEUTICS, INC. | 2011 | third_quarter | MED | Assisting with PAHPA reauthorization. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-13T16:16:41.777000-04:00 | |
| 1148409 | PARRY, ROMANI, DECONCINI & SYMMS 78698d2e-c673-4e59-8e7a-2f3ed06775c0 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | AIDS HEALTHCARE FOUNDATION | 2011 | third_quarter | MED | Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011 - Support funding for medical treatment for HIV positive patients. Support appropriate funding for the ADAP program. Continue appropriate funding levels for Chronic Care Special Needs clinics under Medicare. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-13T16:57:24.403000-04:00 | |
| 1148707 | WASHINGTON UNIVERSITY IN ST. LOUIS 829b04ee-2c72-4971-9e4f-52ac45b859b7 | Q3 | WASHINGTON UNIVERSITY IN ST. LOUIS | 40031264 | WASHINGTON UNIVERSITY IN ST LOUIS | 2011 | third_quarter | MED | General advocacy for NIH research, genomics research, and improved conflict of interest policies. Advocacy in support of clear, productive federal stem cell research guidelines. | HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 40000 | 0 | 0 | 2011-10-14T10:37:48.800000-04:00 | |
| 1148728 | AMERICAN DIABETES ASSOCIATION 6290d40a-07c8-49cc-8810-9d234f4e9229 | Q3 | AMERICAN DIABETES ASSOCIATION | 2230 | AMERICAN DIABETES ASSOCIATION | 2011 | third_quarter | MED | H.R. 4808, the Stem Cell Enhancement Act. Support bill. Legislation codifies the Obama Administrations Executive Order and National Institutes of Health guidelines regarding federal funding of human embryonic stem cell research. (Lobbyists used: Lisa Cox) | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE | 141000 | 0 | 0 | 2011-10-14T10:49:18.127000-04:00 | |
| 1148831 | FAEGRE BAKER DANIELS CONSULTING 0ef6ef17-6e92-472d-a1c6-ac03948e1563 | Q3 | FAEGRE BAKER DANIELS CONSULTING | 34158 | LEARNING & EDUCATION ACADEMIC RESEARCH NETWORK | 2011 | third_quarter | MED | NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT RESEARCH GRANTS | Education, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE | 10000 | 0 | 0 | 2011-10-14T11:33:09.453000-04:00 | |
| 1149226 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 2ec0df53-b1e8-4170-b1bb-4cf6d169e653 | Q3 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | PATH | 2011 | third_quarter | MED | Monitor issues related to global health and technology. Track USG activity and expenditures on medical research and development. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-10-14T13:58:48.053000-04:00 | |
| 1149333 | THE PETRIZZO GROUP, INC. b976e1dc-064b-47d3-b6ce-e08626211ac4 | Q3 | THE PETRIZZO GROUP, INC. | 305932 | SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION | 2011 | third_quarter | MED | Advocated for legislation to create pediatric research hubs to maximize the impact of existing pediatric research capacity and boost funding for research benefitting children. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-14T14:32:36.037000-04:00 | |
| 1149473 | FOLEY & LARDNER LLP f8628f61-0660-41d2-96ec-1d465817c7cc | Q3 | FOLEY & LARDNER LLP | 15042 | ROMARK LABORATORIES, LC | 2011 | third_quarter | MED | Sale of new anti-viral drug | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-10-14T15:28:47.940000-04:00 | ||
| 1149483 | FOLEY & LARDNER LLP 97e95db4-6f69-4598-9d0e-d16d83dd6683 | Q3 | FOLEY & LARDNER LLP | 15042 | PHOENIX NUCLEAR LABS LLC | 2011 | third_quarter | MED | Legislation to promote development of radio-isotopes for medical diagnostics and therapy | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-10-14T15:32:56.410000-04:00 | ||
| 1149550 | FOLEY & LARDNER LLP 489d5dff-aad1-44da-bd87-fe44dd9b156c | Q3 | FOLEY & LARDNER LLP | 15042 | FLUGEN, INC. | 2011 | third_quarter | MED | Funding for vaccine research and development and vaccine delivery product. | Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-10-14T15:46:32.113000-04:00 | ||
| 1149662 | TCH GROUP, LLC c4a46ded-605e-4858-b45e-587c99f6beaf | Q3 | TCH GROUP, LLC | 51478 | SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) | 2011 | third_quarter | MED | General discussion regarding the reauthorization of the Prescription Drug User Fee Act (PDUFA); and education and awareness of vaccine production and infrastructure needs | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-10-14T16:43:46.377000-04:00 | |
| 1149707 | GROUP HEALTH COOPERATIVE 0c8bac11-72d1-48c5-9834-62cb90e1ac94 | Q3 | GROUP HEALTH COOPERATIVE | 17022 | GROUP HEALTH COOPERATIVE | 2011 | third_quarter | MED | Issues related to health reform legislation and regulation including Medicare Advantage; insurance regulation changes; insurance taxes; health cooperatives; health systems reserach topics such as the patient-centered medical home; the Patient Protection and Affordable Care Act. | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,White House Office | 110000 | 0 | 0 | 2011-10-14T16:57:08.283000-04:00 | |
| 1149865 | THE CJR GROUP, INC. 58e745a6-de76-4797-bca3-610ec40fe895 | Q3 | THE CJR GROUP, INC. | 288293 | STERIS CORPORATION | 2011 | third_quarter | MED | Biomedical issues | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-15T09:57:41-04:00 | |
| 1149869 | THE CJR GROUP, INC. 98f66d88-e0b0-44d9-908e-39f6ad517a6c | Q3 | THE CJR GROUP, INC. | 288293 | UNIVERSITY HOSPITALS HEALTH SYSTEM | 2011 | third_quarter | MED | Medical issues relating to hospitals | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-15T10:03:42.827000-04:00 | |
| 1149926 | BEN BARNES GROUP LP 561040be-9752-4a6f-a717-9ef08ec177cc | Q3 | BEN BARNES GROUP LP | 5415 | OKLAHOMA RESEARCH MEDICAL FOUNDATION | 2011 | third_quarter | MED | Medical Research | SENATE | 20100 | 0 | 0 | 2011-10-15T14:05:06.447000-04:00 | |
| 1149996 | PERSONALIZED MEDICINE COALITION 33733fdc-3fa5-48c0-8ad0-c101c56377dc | Q3 | PERSONALIZED MEDICINE COALITION | 40046362 | PERSONALIZED MEDICINE COALITION | 2011 | third_quarter | MED | CER, CMS, Coverage of Genetic Testing | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 6499 | 0 | 0 | 2011-10-15T22:04:07.350000-04:00 | |
| 1150045 | AKIN GUMP STRAUSS HAUER & FELD 3e5e0971-47ae-4066-bcc2-dadc8bf82e6f | Q3 | AKIN GUMP STRAUSS HAUER & FELD | 682 | NOVARTIS CORPORATION | 2011 | third_quarter | MED | Issues related to the importance of vaccines | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2011-10-16T15:55:25.207000-04:00 | |
| 1150596 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 29be2f14-bdd6-49db-975d-37b3414664f7 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ONYX PHARMACEUTICALS | 2011 | third_quarter | MED | Innovation in biotechnology; biosimilars; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-17T11:27:41.357000-04:00 | |
| 1150688 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9f449e49-7144-492d-afca-32c4abadf2da | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NAVIGENICS, INC. | 2011 | third_quarter | MED | Oversight and regulation of genetic testing. Direct to consumer genetic testing. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-10-17T11:51:25.530000-04:00 | |
| 1150716 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b72a1368-daff-4b5b-86e3-b2f75ffbc94d | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | TETHYS BIOSCIENCE | 2011 | third_quarter | MED | Regulation of laboratory developed tests. No Bill #: BETTER Patient Care Act | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-17T11:59:37.277000-04:00 | |
| 1150735 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. cc03d1f0-ab20-4358-a88a-c1709d79b437 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2011 | third_quarter | MED | Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 1249, American Invents Act | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE | 30000 | 0 | 0 | 2011-10-17T12:10:47.873000-04:00 | |
| 1150865 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 011af3e5-b0d4-4a7f-95c2-7488af7a44c9 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL HEMOPHILIA FOUNDATION | 2011 | third_quarter | MED | Hemophilia research, prevention, surveillance and service programs and issues. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2011-10-17T12:53:39.483000-04:00 | |
| 1150890 | AMERICAN ASSOCIATION FOR CANCER RESEARCH 19a6ea21-be07-46dc-8ed6-dd025ae04b73 | Q3 | AMERICAN ASSOCIATION FOR CANCER RESEARCH | 400601833 | AMERICAN ASSOCIATION FOR CANCER RESEARCH | 2011 | third_quarter | MED | upcoming reauthorization of Prescription Drug User Fee Act and Medical Device User Fee Act | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2011-10-17T12:59:51.013000-04:00 | |
| 1150906 | CALIFORNIA LIFE SCIENCES d9a45920-ecaa-42b0-a281-2d0831b1b6dd | Q3 | CALIFORNIA LIFE SCIENCES | 7758 | CALIFORNIA LIFE SCIENCES | 2011 | third_quarter | MED | Support NIH funding. | HOUSE OF REPRESENTATIVES,SENATE | 140000 | 0 | 0 | 2011-10-17T13:01:54.560000-04:00 | |
| 1150908 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 3ea52269-8e4a-4232-b2f3-6227f856e7fe | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN SOCIETY OF HEMATOLOGY | 2011 | third_quarter | MED | Research in hematology. | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2011-10-17T13:02:55.513000-04:00 | |
| 1150925 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 284930a8-0040-49c5-a746-ea87f306d2ae | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ASSOCIATION OF AMERICA'S BLOOD BANKS | 2011 | third_quarter | MED | Blood safety and management issues. HHS Advisory Committee on Blood Safety and Availability. Research related to Biovigilance. | Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-17T13:07:03.683000-04:00 | |
| 1150944 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. d5f5a18f-f54e-4121-b136-cfee33319b54 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION | 2011 | third_quarter | MED | S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, biomedical research HR 2219, Defense Appropriations Bill, FY 2012, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2011-10-17T13:17:14.450000-04:00 | |
| 1150962 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 040042d9-510b-4303-99eb-596a7eb418b4 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION | 2011 | third_quarter | MED | S. 1599, Labor/HHS/Education Appropriations Bill, FY 2012, HHT research HR 2123/S 1167, Hereditary Hemorrhagic Telangiectasia Diagnosis and Treatment Act of 2011. | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-17T13:20:19.687000-04:00 | |
| 1151050 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 208b4c5c-afbe-45b1-beee-01356877a028 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | TUBEROUS SCLEROSIS ALLIANCE | 2011 | third_quarter | MED | S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, Tuberous Sclerosis HR 1473, Defense Appropriations Bill, FY 2011, Tuberous Sclerosis Complex Research Program | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2011-10-17T14:05:49.277000-04:00 | |
| 1151070 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 87b2f34d-92b1-4eff-8e09-d4f3df1fdd02 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | SAGE PUBLICATIONS, INC. | 2011 | third_quarter | MED | No Bill#, Federal Research Public Access Act National Institutes of Health Open Access policy No Bill#, America COMPETES Act, implementation of public access policy at federal science agencies S. 1599, Labor-HHS-Education Appropriations Bill, FY 2012, NIH Open Access Policy, Department of Education Title II Funding No Bill#, Reauthorization of Elementary and Secondary Education Act, Title II Funding | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-17T14:09:54.977000-04:00 | |
| 1151112 | BALCH & BINGHAM, LLP 66e7e4b3-9a6d-428e-a417-d5b980417981 | 3T | BALCH & BINGHAM, LLP | 5197 | BIOCRYST PHARMACEUTICALS INC | 2011 | third_quarter | MED | Programs, regulations and legislation pertaining to: Project Bioshield; Federal pandemic preparedness and response; the Biomedical Advanced Research and Development Authority; the Food & Drug Administration. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 1 | 2011-10-17T14:21:15.357000-04:00 | |
| 1151137 | PARRY, ROMANI, DECONCINI & SYMMS 9e878fe1-f6fa-4160-ad8f-1275a08de954 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | BRAIDWOOD MANAGEMENT, INC. | 2011 | third_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-10-17T14:27:27.150000-04:00 | |
| 1151186 | PARRY, ROMANI, DECONCINI & SYMMS 128133c7-36ec-4fb9-8aa1-c54f21cf7ff1 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | DIAMONDBACK DRUGS | 2011 | third_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 6000 | 0 | 0 | 2011-10-17T14:36:45.987000-04:00 | |
| 1151287 | POLICY DIRECTIONS INC. 35ac5cb3-41cd-4fa4-a552-c1c7eddd7c9c | Q3 | POLICY DIRECTIONS INC. | 31747 | BAYLOR COLLEGE OF MEDICINE | 2011 | third_quarter | MED | S. 606 and HR 3059- Creating Hope Act of 2011 - issues related to neglected tropical disease research and treatment. HR 528 - Neglected Infections of Impoverished Americans Act of 2011. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-17T14:56:25.567000-04:00 | |
| 1151291 | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS 13671ab3-e55e-48b6-824d-c88b2a18c0fe | Q3 | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | 1375 | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | 2011 | third_quarter | MED | Improving health quality measures and enhancing the activities of the Agency for Health Research and Quality (AHRQ) | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE | 7087 | 0 | 0 | 2011-10-17T14:59:28.850000-04:00 | |
| 1151424 | PARRY, ROMANI, DECONCINI & SYMMS 083d9071-19ea-483c-bfd0-464b908be417 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | VETERINARY PHARMACIES OF AMERICA, INC. | 2011 | third_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-10-17T15:22:15.357000-04:00 | |
| 1151450 | PARRY, ROMANI, DECONCINI & SYMMS 9b1a94b1-063d-442e-9416-24e4290aeeb5 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2011 | third_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-10-17T15:28:25.090000-04:00 | |
| 1151517 | PARRY, ROMANI, DECONCINI & SYMMS 5d125bb2-465d-433b-bbe4-a640a626165f | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WOMEN'S INTERNATIONAL PHARMACY, INC. | 2011 | third_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2011-10-17T15:37:42.997000-04:00 | |
| 1151574 | THE CORMAC GROUP, LLC f3e7b773-a448-4821-9bdb-a26fb6a5da35 | Q3 | THE CORMAC GROUP, LLC | 66773 | KESSLER FOUNDATION | 2011 | third_quarter | MED | Appropriations, DOD | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2011-10-17T15:56:11.530000-04:00 | |
| 1151632 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. f81d38f5-35a9-4e6e-bf20-78eafbf9f695 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | STATE UNIVERSITY SYSTEM OF FLORIDA | 2011 | third_quarter | MED | Appropriations and Authorization legislation for FY 2012 in health care HR3070/S.1599 | Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE | 70000 | 0 | 0 | 2011-10-17T16:10:30.870000-04:00 | |
| 1151671 | PARRY, ROMANI, DECONCINI & SYMMS 6265b7ba-762d-4d2b-9318-74c16548ca86 | Q3 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) | 2011 | third_quarter | MED | General discussions regarding the rauthorization of the Prescription Drug User Fee Act (PDUFA); and education and awareness of vaccine production and infrastructure needs. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-17T16:25:46.260000-04:00 | |
| 1151682 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 085b22e0-e9e7-4b62-8fe4-00cb9248c010 | 3A | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | STATE UNIVERSITY SYSTEM OF FLORIDA | 2011 | third_quarter | MED | Appropriations and Authorization legislation for FY 2012 in health care HR3070/S.1599 | Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE | 70000 | 0 | 0 | 2011-10-17T16:28:49.560000-04:00 | |
| 1151687 | FAEGRE DRINKER BIDDLE & REATH LLP 6b4c5ba0-469d-44e1-a947-e42ab05cea35 | Q3 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2011 | third_quarter | MED | Public Health Programs for Infectious and Tropical Disease; Issues related to Neglected Disease Product Approval; H.R. 528 - Neglected Infections of Impoverished Americans Act; CDC Infection and Vector Borne Disease Programs; S. Con. Res. 115 - World Malaria Day Resolution; S. 606 - Creating Hope Act of 2011; H.R. 2144 - 21st Century Global Technology Act. | Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID) | 30000 | 0 | 0 | 2011-10-17T16:29:51.230000-04:00 | |
| 1151693 | FAEGRE DRINKER BIDDLE & REATH LLP 64aacadc-beab-4af9-aa39-d777724f4eca | Q3 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | RIVERAIN MEDICAL | 2011 | third_quarter | MED | Increasing awareness of lung cancer and making it a public health priority | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-17T16:32:55.747000-04:00 | |
| 1151704 | FAEGRE DRINKER BIDDLE & REATH LLP 83a252ac-333e-41c4-a1b4-5024059ed668 | Q3 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | PREVENT BLINDNESS | 2011 | third_quarter | MED | Eye Disease and Vision Health; Treatment and Prevention of Blindness and Vision Loss. | Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 40000 | 0 | 0 | 2011-10-17T16:35:00.823000-04:00 | |
| 1151793 | LATHAM & WATKINS LLP b551e569-42f3-415c-87ae-a5accbc0f882 | Q3 | LATHAM & WATKINS LLP | 22201 | BOSTON SCIENTIFIC CORPORATION | 2011 | third_quarter | MED | Congressional oversight of the Food and Drug Administration. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-10-17T16:53:39.997000-04:00 | |
| 1151796 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 5151403a-f776-484b-9551-ac9ad4618b05 | Q3 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | COOLEY'S ANEMIA FOUNDATION | 2011 | third_quarter | MED | Drug review and approval process | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-17T16:53:41.293000-04:00 | |
| 1151810 | INFECTIOUS DISEASES SOCIETY OF AMERICA 36c5b0ec-c9e1-4e03-a0fc-2548f1e67945 | Q3 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 54836 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 2011 | third_quarter | MED | Medical liability; antimicrobial resistance research; infectious diseases product research and development; regulatory science; unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; and support for evidence-based decision making. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Agency for International Development (USAID) | 102889 | 0 | 0 | 2011-10-17T16:54:45.730000-04:00 | |
| 1151844 | FAEGRE DRINKER BIDDLE & REATH LLP ad0bab1b-5c36-4274-90e1-a79aa0e18b05 | Q3 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | SMITH & NEPHEW, INC. | 2011 | third_quarter | MED | Issues Related to Arthritis. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE,Veterans Affairs, Dept of (VA) | 50000 | 0 | 0 | 2011-10-17T16:59:59.167000-04:00 | |
| 1151882 | FAEGRE DRINKER BIDDLE & REATH LLP 4f0d7d00-ab66-4f98-888f-e7d6a380859a | Q3 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | PREECLAMPSIA FOUNDATION | 2011 | third_quarter | MED | Preeclampsia Research; National Health Calendar. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH) | 10000 | 0 | 0 | 2011-10-17T17:03:11.637000-04:00 | |
| 1151920 | FAEGRE DRINKER BIDDLE & REATH LLP 1428fc21-f0e9-4d83-a8d5-d655beeb4b33 | Q3 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA | 2011 | third_quarter | MED | Public Health and Medical Research Programs for Neglected and Infectious Diseases; H.R. 528 - Neglected Infections of Impoverished Americans Act; S. 606 - Creating Hope Act of 2011. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-10-17T17:07:25.370000-04:00 | |
| 1151961 | FAEGRE DRINKER BIDDLE & REATH LLP 3f5d9940-36f2-4aee-8b3b-dc280a6aa31c | Q3 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | SPINA BIFIDA ASSOCIATION | 2011 | third_quarter | MED | Spina Bifida Research and Awareness and Access to Care; Medical Device User Fee Act. | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE | 40000 | 0 | 0 | 2011-10-17T17:15:46.650000-04:00 | |
| 1152177 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 820c60ce-4f5a-4ea4-8b0f-4e97168636c6 | Q3 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) | 2970 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) | 2011 | third_quarter | MED | No bill #: Advocate for disability and rehabilitation prioirities of the Patient Centered Outcomes Research Institute, espcially regarding comparative effectiveness research. Advocate for elevation of the National Center for Medical Rehabilitation Research within the National Institutes of Health. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE | 100000 | 0 | 0 | 2011-10-17T18:21:09.683000-04:00 | |
| 1152546 | VAN SCOYOC ASSOCIATES 1619f355-69df-4b5a-a3df-90bdf7e0071b | Q3 | VAN SCOYOC ASSOCIATES | 39837 | CORPORATE FRIENDS OF CDC, INC. | 2011 | third_quarter | MED | No lobbying activity. | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2011-10-18T06:19:15.483000-04:00 | |
| 1152787 | SRI INTERNATIONAL 2e9f7b26-aa5d-4f2b-9eaa-f068cebbc6f9 | Q3 | SRI INTERNATIONAL | 90990 | SRI INTERNATIONAL | 2011 | third_quarter | MED | FY12 House and Senate Defense Appropriations (HR 2219) FY12 House and Senate Defense Authorizations (HR 1540/S 1253) Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 (HR 2405) | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2011-10-18T09:40:53.100000-04:00 | |
| 1152925 | MCDERMOTT WILL & SCHULTE LLP 3bf1a73b-902a-4235-ab5d-c840764d4243 | Q3 | MCDERMOTT WILL & SCHULTE LLP | 24338 | COALITION FOR 21ST CENTURY MEDICINE | 2011 | third_quarter | MED | Issues concerning regulation of laboratory tests. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2011-10-18T10:10:48.797000-04:00 | |
| 1152995 | MCDERMOTT WILL & SCHULTE LLP 2b095093-1d54-4d83-9329-946b69a71fdd | Q3 | MCDERMOTT WILL & SCHULTE LLP | 24338 | GENOMIC HEALTH INC | 2011 | third_quarter | MED | FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests. | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2011-10-18T10:20:19.173000-04:00 | |
| 1153072 | DENNY MILLER ASSOCIATES 800182f1-4d4f-4ce8-afc7-7c8cf281ec33 | Q3 | DENNY MILLER ASSOCIATES | 25328 | CELL THERAPEUTICS | 2011 | third_quarter | MED | FDA appeal process for new drug applications. FDA process for approving clinical trials for new drug applications. Federal support for biotechnology companies. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-18T10:26:49.823000-04:00 | |
| 1153186 | BLANK ROME GOVERNMENT RELATIONS 8a858f76-c937-4718-bdab-d786c9a08bee | Q3 | BLANK ROME GOVERNMENT RELATIONS | 6325 | SELECT GREATER PHILADELPHIA (FORMERLY LISTED AS THE CEO COUNCIL FOR GROWTH) | 2011 | third_quarter | MED | Issues relating to laboratory space | Centers For Disease Control & Prevention (CDC) | 20000 | 0 | 0 | 2011-10-18T10:41:37.150000-04:00 | |
| 1153995 | DENNY MILLER ASSOCIATES e7321ce9-c751-422d-84ce-8c6334d72b4a | Q3 | DENNY MILLER ASSOCIATES | 25328 | SABEY CORPORATION | 2011 | third_quarter | MED | Oversight and implementation of the Patient Protection and Affordable Care Act (PL 111-148), provisions relating to the Center for Medicare and Medicaid Innovation grant program. Federal grant funding through the Department of Health and Human Services. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2011-10-18T13:02:07.807000-04:00 | |
| 1154064 | GRAY & OSCAR, LLC (FORMERLY BOB GRAY, LLC) 659ebcdc-74d1-41a5-94ae-6f55c989bc2a | Q3 | GRAY & OSCAR, LLC (FORMERLY BOB GRAY, LLC) | 33124 | IMX MEDICAL MANAGEMENT SERVICES | 2011 | third_quarter | MED | No specific legislative activities - .Continued to meet with members of Pennsylvania Congressional delegation to brief them on IMX's efforts to have their medical evaluation services given consideration by the Department of Veterans Affairs and the Department of Defense. Also held meetings with officials at Department of Veterans Affairs and Department of defense to discuss their procurement procedures for additional medical services. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 5000 | 0 | 0 | 2011-10-18T13:10:32.633000-04:00 | |
| 1154072 | PARKINSON'S ACTION NETWORK a83a85b1-4e0a-444f-acc8-a14f0d11a1c4 | Q3 | PARKINSON'S ACTION NETWORK | 285676 | PARKINSON'S ACTION NETWORK | 2011 | third_quarter | MED | H.R. 2595/S.425, "The National Neurological Diseases Surveillance System Act," all sections; "all sections relating to the National Insitutes of Health (NIH), Cures Acceleration Network, and the National Center for Advancing Translational Sciences"; "Department of Defense Appropriations," sec. related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) progarm; Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2012," all sections FDA; Prescription Drug User Fee Act (PDUFA) V; Medical Device User Fee Act (MDUFA) IV; the Balanced Budget Act of 1997 (sections related to amending Medicare therapy caps). | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2011-10-18T13:11:35.633000-04:00 | ||
| 1154080 | CASSIDY & ASSOCIATES, INC. 1146836b-34ef-4f46-9230-16c6bdd0edb3 | Q3 | CASSIDY & ASSOCIATES, INC. | 8453 | LINDE NORTH AMERICA, INC. | 2011 | third_quarter | MED | Legislation related to the Food and Drug Administration HR2227, the Medical Gas Act | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-18T13:12:38.837000-04:00 | |
| 1154192 | DENNY MILLER ASSOCIATES 6ac6391f-ca11-4dea-8cbb-a1bd5ff1d941 | Q3 | DENNY MILLER ASSOCIATES | 25328 | ST PATRICK HOSPITAL AND HEALTH SCIENCE CENTER | 2011 | third_quarter | MED | S 1599, Labor, Health and Human Services, and Education Appropriations Bills, FY 2012, Title II, provisions relating to rural health care. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2011-10-18T13:32:24.037000-04:00 | |
| 1154253 | FAEGRE DRINKER BIDDLE & REATH LLP 5abcd4be-349c-415a-9cdb-60cddbf83f39 | Q3 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | NATIONAL PSORIASIS FOUNDATION | 2011 | third_quarter | MED | H.R. 2033/S.1107 - Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011; Psoriasis Data Collection. | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,White House Office | 50000 | 0 | 0 | 2011-10-18T13:39:49.900000-04:00 | |
| 1154300 | BROWNSTEIN HYATT FARBER SCHRECK, LLP 40375ee4-b261-4dc2-b062-3306941d1e98 | Q3 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | 7257 | ABBOTT LABORATORIES | 2011 | third_quarter | MED | Healthcare reform | 60000 | 0 | 0 | 2011-10-18T13:49:13.727000-04:00 | ||
| 1154410 | PARALYZED VETERANS OF AMERICA 22972ccc-8af4-40dc-ba68-1924775b590d | Q3 | PARALYZED VETERANS OF AMERICA | 30724 | PARALYZED VETERANS OF AMERICA | 2011 | third_quarter | MED | Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues | HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA) | 81128 | 0 | 0 | 2011-10-18T14:09:01.777000-04:00 | |
| 1154628 | MCDERMOTT WILL & SCHULTE LLP 0e66da02-3012-4a12-9b4c-ceab8527cda8 | Q3 | MCDERMOTT WILL & SCHULTE LLP | 24338 | ISIS PHARMACEUTICALS | 2011 | third_quarter | MED | Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249. | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2011-10-18T14:31:28.007000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);